Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Главный автор: | Siddika, Khadiza |
---|---|
Другие авторы: | Ahmed, Syeda Maliha |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2024
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/24296 |
Схожие документы
-
Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
по: Rattry, Faria Rahman
Опубликовано: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024) -
Molecular biology : genes to proteins /
по: Tropp, Burton E.
Опубликовано: (2008)